UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (5182) 5182
Newsletter (173) 173
Dissertation (71) 71
Newspaper Article (54) 54
Magazine Article (47) 47
Book Chapter (37) 37
Conference Proceeding (11) 11
Publication (6) 6
Web Resource (4) 4
Transcript (2) 2
Paper (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (3181) 3181
alendronate (3023) 3023
life sciences & biomedicine (2973) 2973
humans (2966) 2966
female (2505) 2505
osteoporosis (2044) 2044
alendronate - therapeutic use (1807) 1807
aged (1333) 1333
middle aged (1329) 1329
male (1216) 1216
biological and medical sciences (1108) 1108
animals (1033) 1033
medical sciences (1021) 1021
bone density conservation agents - therapeutic use (955) 955
alendronate - administration & dosage (929) 929
bone density - drug effects (893) 893
bisphosphonates (881) 881
osteoporosis, postmenopausal - drug therapy (869) 869
alendronate - pharmacology (856) 856
endocrinology & metabolism (824) 824
osteoporosis - drug therapy (823) 823
alendronate - adverse effects (790) 790
pharmacology. drug treatments (679) 679
bone density (626) 626
orthopedics (578) 578
bone density conservation agents - administration & dosage (547) 547
bone density conservation agents - adverse effects (539) 539
aged, 80 and over (536) 536
drug therapy (527) 527
rats (520) 520
bones (514) 514
fractures (513) 513
abridged index medicus (510) 510
research (500) 500
adult (492) 492
risk factors (487) 487
bones, joints and connective tissue. antiinflammatory agents (481) 481
diphosphonates - therapeutic use (481) 481
treatment outcome (455) 455
general & internal medicine (416) 416
pharmacology & pharmacy (416) 416
medicine, general & internal (405) 405
health aspects (397) 397
bisphosphonate (391) 391
bone density conservation agents - pharmacology (390) 390
medicine & public health (381) 381
diseases of the osteoarticular system (378) 378
etidronic acid - analogs & derivatives (362) 362
bone mineral density (360) 360
dentistry (351) 351
rheumatology (351) 351
analysis (348) 348
care and treatment (344) 344
alendronic acid (342) 342
postmenopausal women (337) 337
time factors (324) 324
risedronate sodium (323) 323
administration, oral (312) 312
diphosphonates - administration & dosage (300) 300
etidronic acid - therapeutic use (289) 289
diphosphonates - adverse effects (279) 279
fractures, bone - prevention & control (277) 277
osteoporosis. osteomalacia. paget disease (270) 270
density (260) 260
mice (259) 259
bone remodeling - drug effects (255) 255
double-blind method (255) 255
dentistry, oral surgery & medicine (253) 253
surgery (249) 249
diphosphonates - pharmacology (245) 245
endocrinology (242) 242
drug administration schedule (236) 236
fundamental and applied biological sciences. psychology (236) 236
bone and bones - drug effects (233) 233
rats, sprague-dawley (232) 232
absorptiometry, photon (229) 229
dosage and administration (228) 228
diphosphonates (225) 225
dose-response relationship, drug (219) 219
risedronate (216) 216
drug therapy, combination (213) 213
ovariectomy (207) 207
osteoporosis - prevention & control (206) 206
radiography (205) 205
follow-up studies (203) 203
physical sciences (200) 200
phosphonates (196) 196
prevention (196) 196
technology (191) 191
denosumab (189) 189
retrospective studies (189) 189
bone resorption (186) 186
medicine, research & experimental (185) 185
research & experimental medicine (184) 184
alendronate - chemistry (180) 180
women (180) 180
osteoclasts - drug effects (177) 177
disease models, animal (173) 173
chemistry (172) 172
rats, wistar (172) 172
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (5079) 5079
Portuguese (111) 111
Japanese (109) 109
German (106) 106
Spanish (83) 83
French (46) 46
Chinese (39) 39
Korean (37) 37
Italian (24) 24
Russian (23) 23
Norwegian (21) 21
Turkish (21) 21
Polish (19) 19
Danish (10) 10
Slovak (6) 6
Croatian (5) 5
Czech (5) 5
Dutch (5) 5
Hungarian (4) 4
Swedish (4) 4
Finnish (2) 2
Persian (2) 2
Serbian (2) 2
Ukrainian (2) 2
Bulgarian (1) 1
Hebrew (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England journal of medicine, ISSN 0028-4793, 10/2017, Volume 377, Issue 15, pp. 1417 - 1427
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Humans | Antibodies, Monoclonal - adverse effects | Fractures, Bone - epidemiology | Antibodies, Monoclonal - therapeutic use | Risk | Bone Remodeling - drug effects | Alendronate - therapeutic use | Incidence | Spinal Fractures - prevention & control | Female | Drug Therapy, Combination | Bone Density Conservation Agents - adverse effects | Double-Blind Method | Antibodies, Monoclonal - pharmacology | Spinal Fractures - epidemiology | Bone Density Conservation Agents - therapeutic use | Osteoporosis, Postmenopausal - drug therapy | Bone Density Conservation Agents - pharmacology | Alendronate - adverse effects | Bone Density - drug effects | Alendronate - pharmacology | Least-Squares Analysis | Aged | Cardiovascular Diseases - chemically induced | Fractures, Bone - prevention & control | Treatment outcome | Care and treatment | Fractures | Growth | Analysis | Monoclonal antibodies | Bones | Research | Jaw | Femur | Vertebrae | Immunoglobulins | Inhibitor drugs | Osteonecrosis | SOST protein | Bisphosphonates | Hip | Post-menopause | Bone resorption | Osteoporosis | Alendronic acid | Bone growth | Bone density | Drug therapy | Osteogenesis | Index Medicus | Abridged Index Medicus | randomized-trial | metaanalysis | disease | postmenopausal women | strength | bone-mineral density | Klinisk medicin | vertebral fractures | sclerosteosis | Clinical Medicine | aorta | risk
Journal Article
Journal Article
The New England journal of medicine, ISSN 0028-4793, 11/2007, Volume 357, Issue 20, pp. 2028 - 2039
Journal Article
Indian journal of endocrinology and metabolism, ISSN 2230-8210, 7/2020, Volume 24, Issue 4, pp. 293 - 294
Journal Article
Osteoporosis international, ISSN 0937-941X, 1/2012, Volume 23, Issue 1, pp. 305 - 315
Osteoporosis | Medicine & Public Health | Alendronate | Orthopedics | Gynecology | Rheumatology | Finite elements analysis | Strontium ranelate | HR-pQCT | Microstructure | Endocrinology | HRpQCT | Life Sciences & Biomedicine | Endocrinology & Metabolism | Science & Technology | Bone and Bones - pathology | Thiophenes - therapeutic use | Radius - pathology | Humans | Middle Aged | Osteoporosis, Postmenopausal - pathology | Tomography, X-Ray Computed | Tibia - pathology | Alendronate - therapeutic use | Bone and Bones - drug effects | Bone and Bones - diagnostic imaging | Osteoporosis, Postmenopausal - diagnostic imaging | Radius - drug effects | Organometallic Compounds - therapeutic use | Female | Finite Element Analysis | Lumbar Vertebrae - physiopathology | Double-Blind Method | Tibia - diagnostic imaging | Bone Density Conservation Agents - therapeutic use | Thiophenes - pharmacology | Tibia - drug effects | Osteoporosis, Postmenopausal - drug therapy | Bone Density Conservation Agents - pharmacology | Bone Density - drug effects | Alendronate - pharmacology | Femur Neck - physiopathology | Osteoporosis, Postmenopausal - physiopathology | Aged | Organometallic Compounds - pharmacology | Radius - diagnostic imaging | Structure | Bones | Analysis | Index Medicus | Dual energy X-ray absorptiometry | Radius | Transformation | Bone turnover | Bisphosphonates | Stress | Post-menopause | Strontium | Alendronic acid | Fractures | Computed tomography | Tibia | Risk assessment | Bone mineral density | Bone strength | Age
Journal Article
Biomaterials, ISSN 0142-9612, 2013, Volume 34, Issue 15, pp. 3795 - 3806
Advanced Basic Science | Dentistry | Angiogenesis | Dendrimers | PEG | Bone targeting | Alendronate | Polymer therapeutics | Engineering | Materials Science | Technology | Engineering, Biomedical | Materials Science, Biomaterials | Science & Technology | Neovascularization, Physiologic - drug effects | Paclitaxel - pharmacology | Human Umbilical Vein Endothelial Cells - metabolism | Apoptosis - drug effects | Humans | Bone Neoplasms - secondary | Polyethylene Glycols - chemistry | Antineoplastic Agents - therapeutic use | Paclitaxel - pharmacokinetics | Tibia - pathology | Alendronate - chemistry | Alendronate - therapeutic use | Paclitaxel - chemistry | Human Umbilical Vein Endothelial Cells - cytology | Micelles | Female | Antineoplastic Agents - pharmacokinetics | Antineoplastic Agents - pharmacology | Bone Neoplasms - drug therapy | Alendronate - pharmacokinetics | Tissue Distribution - drug effects | Human Umbilical Vein Endothelial Cells - drug effects | Treatment Outcome | Antineoplastic Agents - chemistry | Tibia - drug effects | Breast Neoplasms - drug therapy | Paclitaxel - therapeutic use | Xenograft Model Antitumor Assays | Animals | Fluorescein-5-isothiocyanate | Breast Neoplasms - pathology | Alendronate - pharmacology | Cell Line, Tumor | Cell Proliferation - drug effects | Mice | Ethylene glycol | Care and treatment | Phosphonates | Paclitaxel | Aluminum compounds | Fluorescence | Breast cancer | Metastasis | Drug therapy | Cancer | Index Medicus | Drugs | Imaging | Breast | Bones | Conjugation | Tumors
Journal Article